Breaking News

How pharma fares on human rights principles; another push for a controversial drug pricing measure

 

Pharmalot Ed Silverman

STAT+: Pharma largely failed to follow human rights principles with its Covid-19 vaccines and drugs

By Ed Silverman

Adobe

Too few companies performed well "to restore the power balance in favor of human rights,” said the Pharmaceutical Accountability Foundation.

Read More

STAT+: 100 lawmakers ask HHS to use controversial federal laws to combat high drug prices

By Ed Silverman

Rich Pedroncell/AP

The lawmakers reiterated calls to invoke march-in rights or another law that would allow the federal government to sidestep patents.

Read More

STAT+: What we know — and what we may never know — about why the FDA banned Juul

By Nicholas Florko

Justin Sullivan/Getty Images

STAT spoke with several tobacco regulatory experts about the FDA’s issues with Juul’s toxicology data. They were surprised by its reasoning.

Read More

Tracking an FDA advisory panel meeting on updating Covid vaccines

By Helen Branswell and Matthew Herper

Eugene Hoshiko/AP

The Vaccines and Related Biological Products Advisory Committee is meeting to discuss key issues about the composition of Covid vaccines.

Read More

Tuesday, June 28, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments